Optimal Application Timing of ADC Drugs for Advanced Breast Cancer

Clinical trial NCT07657130 · RECRUITING

Trial details

NCT number: NCT07657130
Sponsor: Liaoning Cancer Hospital & Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Females

Start date: 2025-07-01
Primary completion: 2026-06-30
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.